Products and Services
-
Silo Pharma announced that it has signed a license agreement with Medspray Pharma for the use of Medspray’s soft mist spray technology for delivery of Silo’s SPC-15 intranasal ketamine. According to Silo, the Medspray technology… Read more . . .
-
Australian CDMO Ab Initio Pharma has announced the opening of a new R&D facility in Sydney, which the company says is “fitted out to provide state-of-the-art testing and R&D services to Australian and overseas companies… Read more . . .
-
OINDP testing specialists Copley Scientific have launched new versions of their Vertus automated shake and fire system for testing of MDIs and nasal sprays. According to Copley, the Vertus III+ is “comprehensively updated to meet testing requirements… Read more . . .
-
TFF Pharmaceuticals has published a paper on bioRxiv titled “Feasibility of Intranasal Delivery of Thin-film Freeze-dried Monoclonal Antibodies” describing characterization and deposition studies of TFF’s dry powder AUG-3387 mAbs delivered by Aptar Pharma‘s Unidose (UDS)… Read more . . .
-
The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC‑RS) is highlighting the recent publication of a new paper titled “Laboratory Performance Testing of Aqueous Nasal Inhalation Products for Droplet/Particle Size Distribution: an Assessment from… Read more . . .
-
US-based CDMO Renaissance Lakewood, which offers a wide range of services for nasal spray development and manufacturing, has announced a significant expansion of its laboratories in New Jersey, the company said. The expansion is part… Read more . . .
-
Copley Scientific has announced the launch of its new Patient Exhalation Simulator (PES) for use in dry powder inhaler development. According to Copley, the PES simulates exhalation into a DPI prior to inhalation of the… Read more . . .
-
Propellant manufacturer Honeywell and CDMO Recipharm are partnering on development of MDIs formulated with Honeywell’s Solstice Air lower-GWP propellant, the companies said. Honeywell announced in October 2022 that it had started large scale manufacturing of… Read more . . .
-
Marinomed Biotech has announced that its Solv4U unit is working with SPH Sine Pharmaceutical Laboratories to develop an OINDP formulation using Marinomed’s Marinosolv solubility enhancement technology. According to Marinomed, a feasibility study has been completed,… Read more . . .
-
The UK’s Life Sciences Innovation Manufacturing Fund, which provides public/private investment to the life sciences industry, has awarded a grant to CDMO Kindeva Drug Delivery. According to a UK government press release, “The investment will create… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland